{"schema_version":"secwatch.filing_event.v1","accession":"0000721371-23-000005","form_type":"8-K","ticker":"CAH","cik":"0000721371","company_name":"CARDINAL HEALTH INC","filed_at":"2023-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.880482+00:00","generated_at":"2026-06-20T02:57:27.550714+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Cardinal Health Q2 revenue $51.5B, non-GAAP EPS $1.32; raises FY23 guidance","bullets":["Revenue $51.5B, up 13% YoY; GAAP operating loss $119M on $709M goodwill impairment in Medical segment.","Non-GAAP diluted EPS $1.32, up 4% YoY; non-GAAP operating earnings $467M, flat YoY.","Pharmaceutical segment profit $464M (+9%); Medical segment profit $17M (-66%).","FY23 non-GAAP EPS guidance raised to $5.20-$5.50 from $5.05-$5.40; pharma profit growth outlook raised to 4-6.5%.","Interest and other lowered to $115M-$130M from $140M-$160M."],"urls":{"canonical":"https://secwatch.observer/filing/0000721371-23-000005","json":"https://secwatch.observer/filing/0000721371-23-000005.json","markdown":"https://secwatch.observer/filing/0000721371-23-000005.md","text":"https://secwatch.observer/filing/0000721371-23-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/721371/000072137123000005/0000721371-23-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/721371/000072137123000005/cah-20230202.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T02:57:27.550714+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f8df5fd25384424d2c51c4bf94dc26fec9d0967a","claim":"CARDINAL HEALTH INC reported results: revenue $51.5 billion, net income GAAP diluted loss per share was $0.50, EPS $1.32. Guidance raised.","evidence_excerpt":"Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2023 revenues of $51.5 billion, an increase of 13% from the second quarter of fiscal year 2022. Second quarter GAAP operating loss was $119 million due to a non-cash, pre-tax goodwill impairment of $709 million related to the Medical segment. GAAP diluted loss per share was $0.50, primarily due to this impairment, net of tax effects. Second quarter non-GAAP operating earnings of $467 million were in-line with the second quarter of last year. Non-GAAP diluted earnings per share (EPS) increased 4% to $1.32, due to lower interest expense and a lower share count, partially offset by a higher non-GAAP effective tax rate.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/721371/000072137123000005/0000721371-23-000005-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Revenue","value":"$51.5 billion"},{"label":"Net income","value":"GAAP diluted loss per share was $0.50"},{"label":"EPS","value":"$1.32"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}